210 related articles for article (PubMed ID: 33236222)
1. Tumor-infiltrating B cell is associated with the control of progression of gastric cancer.
Ni Z; Xing D; Zhang T; Ding N; Xiang D; Zhao Z; Qu J; Hu C; Shen X; Xue X; Zhou J
Immunol Res; 2021 Feb; 69(1):43-52. PubMed ID: 33236222
[TBL] [Abstract][Full Text] [Related]
2. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
[No Abstract] [Full Text] [Related]
3. The Prognostic Importance of CD20
Edin S; Kaprio T; Hagström J; Larsson P; Mustonen H; Böckelman C; Strigård K; Gunnarsson U; Haglund C; Palmqvist R
Sci Rep; 2019 Dec; 9(1):19997. PubMed ID: 31882709
[TBL] [Abstract][Full Text] [Related]
4. B cells in tertiary lymphoid structures are associated with favorable prognosis in gastric cancer.
Sakimura C; Tanaka H; Okuno T; Hiramatsu S; Muguruma K; Hirakawa K; Wanibuchi H; Ohira M
J Surg Res; 2017 Jul; 215():74-82. PubMed ID: 28688665
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer.
Berntsson J; Nodin B; Eberhard J; Micke P; Jirström K
Int J Cancer; 2016 Sep; 139(5):1129-39. PubMed ID: 27074317
[TBL] [Abstract][Full Text] [Related]
6. Impact of chemokine receptor CXCR3 on tumor-infiltrating lymphocyte recruitment associated with favorable prognosis in advanced gastric cancer.
Li K; Zhu Z; Luo J; Fang J; Zhou H; Hu M; Maskey N; Yang G
Int J Clin Exp Pathol; 2015; 8(11):14725-32. PubMed ID: 26823797
[TBL] [Abstract][Full Text] [Related]
7. Serum CD4 Is Associated with the Infiltration of CD4
You Q; Fang T; Yin X; Wang Y; Yang Y; Zhang L; Xue Y
J Immunol Res; 2021; 2021():6539702. PubMed ID: 34258299
[TBL] [Abstract][Full Text] [Related]
8. Expression of the Chemokine Receptor CXCR3 Correlates with Dendritic Cell Recruitment and Prognosis in Gastric Cancer.
Chen F; Yin S; Niu L; Luo J; Wang B; Xu Z; Yang G
Genet Test Mol Biomarkers; 2018 Jan; 22(1):35-42. PubMed ID: 29266971
[TBL] [Abstract][Full Text] [Related]
9. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the human cytomegalovirus UL111A is correlated with favorable survival of patients with gastric cancer and changes T-cell infiltration and suppresses carcinogenesis.
Liu X; Lin K; Huang X; Xie W; Xiang D; Ding N; Hu C; Shen X; Xue X; Huang Y
J Cancer Res Clin Oncol; 2020 Mar; 146(3):555-568. PubMed ID: 32025866
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of B-cell density in cutaneous melanoma.
Ladányi A; Kiss J; Mohos A; Somlai B; Liszkay G; Gilde K; Fejös Z; Gaudi I; Dobos J; Tímár J
Cancer Immunol Immunother; 2011 Dec; 60(12):1729-38. PubMed ID: 21779876
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Yang KS; Xu CQ; Lv J
Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
[TBL] [Abstract][Full Text] [Related]
13. CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer.
Nielsen JS; Sahota RA; Milne K; Kost SE; Nesslinger NJ; Watson PH; Nelson BH
Clin Cancer Res; 2012 Jun; 18(12):3281-92. PubMed ID: 22553348
[TBL] [Abstract][Full Text] [Related]
14. Margin-infiltrating CD20(+) B cells display an atypical memory phenotype and correlate with favorable prognosis in hepatocellular carcinoma.
Shi JY; Gao Q; Wang ZC; Zhou J; Wang XY; Min ZH; Shi YH; Shi GM; Ding ZB; Ke AW; Dai Z; Qiu SJ; Song K; Fan J
Clin Cancer Res; 2013 Nov; 19(21):5994-6005. PubMed ID: 24056784
[TBL] [Abstract][Full Text] [Related]
15. CD33⁺/p-STAT1⁺ double-positive cell as a prognostic factor for stage IIIa gastric cancer.
Dong J; Li J; Liu SM; Feng XY; Chen S; Chen YB; Zhang XS
Med Oncol; 2013 Mar; 30(1):442. PubMed ID: 23307253
[TBL] [Abstract][Full Text] [Related]
16. The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome.
Arias-Pulido H; Cimino-Mathews A; Chaher N; Qualls C; Joste N; Colpaert C; Marotti JD; Foisey M; Prossnitz ER; Emens LA; Fiering S
Breast Cancer Res Treat; 2018 Sep; 171(2):273-282. PubMed ID: 29858752
[TBL] [Abstract][Full Text] [Related]
17. Peritumoral TIGIT
Liu H; Wu J; Xu X; Wang H; Zhang C; Yin S; He Y
Int Immunopharmacol; 2022 Jul; 108():108735. PubMed ID: 35405596
[TBL] [Abstract][Full Text] [Related]
18. Association of tumor-infiltrating T lymphocytes with intestinal-type gastric cancer molecular subtypes and outcome.
Mansuri N; Birkman EM; Heuser VD; Lintunen M; Ålgars A; Sundström J; Ristamäki R; Lehtinen L; Carpén O
Virchows Arch; 2021 Apr; 478(4):707-717. PubMed ID: 32954467
[TBL] [Abstract][Full Text] [Related]
19. Integrative analysis-based identification and validation of a prognostic immune cell infiltration-based model for patients with advanced gastric cancer.
Pan S; Gao Q; Chen Q; Liu P; Tan Y; Liu F; Xu H
Int Immunopharmacol; 2021 Dec; 101(Pt B):108258. PubMed ID: 34678693
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of B lymphocytes in invasive carcinoma of the breast.
Mahmoud SM; Lee AH; Paish EC; Macmillan RD; Ellis IO; Green AR
Breast Cancer Res Treat; 2012 Apr; 132(2):545-53. PubMed ID: 21671016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
